Verastem Oncology Competitors and Similar CompaniesClear all
Verastem Oncology's competitors and similar companies include Tanvex BioPharma.
 Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. | |
Founding Date | Founding Date 2010 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Needham, US HQ Walsrode, DE | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US |
Employees | Employees 7328% increase | Employees 13827% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) NT$401m (FY, 2025) |
Net income | Net income ($209.5m) (FY, 2025) | Net income (NT$1.5b) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 170m | Total funding raised $ 346.9m |
For sources of this data, please see the company profile
View Company Profiles
Tanvex BioPharma
HQ
Taipei, TW
Employees
138↓ 27% decrease
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
View company